Valion Bio, Inc. (VBIO) vs XORTX Therapeutics Inc. (XRTX)

Valion Bio, Inc. and XORTX Therapeutics Inc. are both Biotechnology companies. Valion Bio, Inc. and XORTX Therapeutics Inc. are of similar size ($3.2M and $3.0M). Across the 11 metrics below, XORTX Therapeutics Inc. leads on 9 and Valion Bio, Inc. on 2.

Valuation

Metric VBIO XRTX Biotechnology median
P/E n/m n/m 7.88
P/S 0.84 n/m 11.47
P/B 0.10 0.50 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales 11.80 n/m 10.73
Earnings yield (6,048.69%) (161.54%) (28.84%)
Free cash flow yield (3,751.73%) (193.17%) (23.03%)

Profitability

Metric VBIO XRTX Biotechnology median
Gross margin (58.09%) 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (489.30%) (99.24%) (57.72%)
Return on assets (104.96%) (83.78%) (49.22%)
Return on invested capital (61.01%) (54.27%) 0.00%

Growth

Metric VBIO XRTX Biotechnology median
Revenue growth (TTM) (49.63%) — 5.64%
EPS growth (last fiscal year) 60.16% 51.30% —
Revenue growth, 5-year CAGR 13.18% — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric VBIO XRTX Biotechnology median
Debt to equity 0.62 0.00 0.00
Current ratio 1.11 3.59 4.73
Net debt to EBITDA 0.79 0.28 0.96

Dividend

Metric VBIO XRTX Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric VBIO XRTX Biotechnology median
Market cap 2.97m 3.17m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack